Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment
NCT02244827
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Impairment
Interventions
DRUG:
WCK 2349
Sponsor
Wockhardt